I bought in at about 30cents when it was valued at about 35...

I bought in at about 30cents when it was valued at about 35 million market cap because there was a peer valuation for 1 billion dollars on something that could be called 'nearology'.

We've had some raisings since then, so its only up 150% (although market cap up 6 times) but I think management have played it really smart.

Management are playing a slow and steady strategy. It means that if the science is any good (it seems better than we all first though tbh), we'll all get nice large gains... Without solvency risks.